Abstract Genetic counseling and testing (GCT) for hereditary breast and ovarian cancers (HBOC) can inform treatment decisions in survivors. Black women at risk of HBOC have lower GCT engagement. There is limited data about Black survivors' experiences. The goals of this study were to: 1) examine the factors associated with HBOC knowledge and 2) assess the impact of knowledge on GCT engagement in a sample of Black survivors at risk of HBOC. Fifty Black at-risk breast/ovarian cancer survivors participated in a telephonebased survey. GCT use was measured across a continuum (awareness, referral, and use). The primary predictor variable was HBOC knowledge. Other clinical, socio-demographic, and psychosocial variables were included. Multiple linear and ordinal regression models (knowledge as the outcome and GCT as the outcome) assessed the predictors of knowledge and GCT engagement. Less than half (48 %) of survivors were referred to or used GCT services. Knowledge was moderate (M = 7.78, SD = 1.61). In the multivariable analysis, lower age (β = −.34, p = .01) and lower stage (β = −.318, p = .017) were associated with higher knowledge. Higher knowledge (β = .567, p = .006) and higher self-efficacy (β = .406, p = .001) were significantly associated with GCT engagement. Future interventions directed at increasing knowledge, self-efficacy, and improving the referral process are warranted.
Introduction
Between 5-10 % of all breast cancer cases are hereditary (Easton and Ford 1995) . Mutations in BRCA1 and BRCA 2 genes (BRCA1/2) are the most commonly identified mutations for hereditary breast and ovarian cancer cases (HBOC; Easton 1999) . The National Comprehensive Cancer Network (NCCN) guidelines recommend referral for genetic cancer risk assessments (genetic counseling and testing as appropriate; GCT) for women at high risk of carrying a mutation (breast cancer diagnosis under age 50, ovarian cancer at any age, bilateral breast cancer, multiple cancers in the same woman, or suggestive family history; National Comprehensive Cancer Network 2015). Obtaining a positive test can inform treatment in newly diagnosed breast cancer patients and management in survivors and unaffected women. (Hamilton et al. 2009; JulianReynier et al. 2011; Rebbeck et al. 2004; Schwartz et al. 2012; Weitzel et al. 2003) . For instance, since survivors with BRCA1/ 2 mutations are at higher risk of contralateral breast cancer than non-mutation carriers (Malone et al. 2010) , having a bilateral mastectomy (vs. unilateral mastectomy) is associated with higher survival rates 20 years post diagnosis (88 % vs. 66 %; Metcalfe et al. 2014) . GCT offered at the time of diagnosis can impact treatment decisions; BRCA1/2 carriers are more likely to choose bilateral mastectomy than breast cancer survivors without the deleterious mutation (Weitzel et al. 2003) . Thus, receipt of timely and recommended GCT may lead to more appropriate treatment decisions and can ultimately impact mortality.
Unfortunately, not all ethnic groups have equally benefited from this technology (Forman and Hall 2009; Hall and Olopade 2005) . Despite having the highest breast cancer morbidity and mortality outcomes of all racial groups (Siegel et al. 2014 ) and the highest breast cancer incidence rates in women under 40 (DeSantis et al. 2014) , the use of GCT is lower in atrisk Black women compared to Whites (Armstrong et al. 2005; Jagsi et al. 2015; Levy et al. 2011) . The under use of beneficial technologies such as GCT may contribute to enhanced disparate outcomes (Daly and Olopade 2015) .
Reasons for under use of GCT in Black women include sociodemographic factors (e.g. marital status), access (e.g. cost), health care factors (e.g. low referrals), and psychosocial factors such as low knowledge, low awareness, medical mistrust, low perceived cancer risk (Glenn et al. 2012; Mays et al. 2012; Sheppard et al. 2013; Sherman et al. 2013) . Few studies have focused only on Black at-risk survivors (Brewster et al. 2007; Halbert et al. 2012; Pal et al. 2013) . Developing strategies that target modifiable factors to increase GCT services use in at-risk Black survivors is critical to improving care and survival outcomes.
Breast cancer genetics knowledge is one modifiable factor that has been associated with genetic counseling/testing use in diverse populations (Butrick et al. 2015) , including in at risk Black women (Kinney et al. 2006; Sherman et al. 2013; Thompson et al. 2002) . Some research suggests that Black women have lower breast cancer genetics knowledge than Whites (Donovan and Tucker 2000; Halbert et al. 1997) . Previous research examined women not at risk for HBOC (Donovan and Tucker 2000; Thompson et al. 2002) , only atrisk unaffected women (Halbert et al. 1997) , or has grouped both affected and unaffected women (Kinney et al. 2006) . Prior research regarding breast cancer genetics knowledge has not targeted at-risk HBOC Black survivors. Thus, there is limited literature on the predictors of knowledge in Black cancer survivors at risk for HBOC. The goals of the study are to (1) examine the factors associated with breast cancer genetics knowledge and (2) assess the impact of breast cancer genetics knowledge on engagement in genetic counseling and testing in a sample of Black breast and ovarian survivors at risk for HBOC. We hypothesized that higher education would be associated with higher GCT knowledge and that higher knowledge would be associated with higher GCT engagement. Findings from this study can help to identify subgroups that could benefit from interventions to enhance breast cancer genetic knowledge that could ultimately increase GCT uptake.
Methods Procedures
This study was conducted in the mid-Atlantic region of the United States. Study procedures were approved by a local Institutional Review Board. This study was nested in a larger project aimed to understand factors associated with Black women's GCT engagement. Details from the setting and procedures of this study have been reported elsewhere (Sheppard et al. 2013) .
Participants were recruited via community-based settings and hospitals (n = 50). Eligible participants were women who self-identified as African American or Black, were 21 years old or older, able to read/understand English, and who were breast or ovarian cancer survivors at risk for hereditary breast cancer. At risk survivors included (1) women diagnosed with breast cancer when they were ≤50 years old (regardless of their family history) or diagnosed at >50 years old with at least one firstdegree relative (e.g. mother) or two second-degree relatives (e.g., aunt) with breast and/or ovarian cancer. A clinical research assistant contacted interested participants by phone, confirmed family and personal history information, consented eligible women, and administered the survey. Participants received a $25 gift card for participating in the study.
Instrumentation

Outcome
GCT Engagement
The main outcome was derived from a sixitem scale with dichotomous response choices (Yes/No) used in prior research (Sheppard et al. 2013 ). The first three items assessed whether participants were aware (Bhave you ever heard about genetic counseling for BRCA1/2?^), had been referred (Bhave you ever been referred for genetic counseling for BRCA1/2?^), and had used genetic counseling services for BRCA1/2 (Bhave you ever received genetic counseling for BRCA 1/2?^). The same three items on awareness, referral, and use were included in relation to genetic testing for BRCA1/2. A summary score that captured overall level of GCT engagement was computed (Kuder-Richardson 20 = .86) with values of 0 (unaware of BRCA1/2 genetic counseling and testing), 1 (aware of either genetic counseling or testing or both, but no referral received), or 2 (received a referral or participated in either counseling or testing or both). Participants were given the highest possible value based on their responses to the 6 items. The purpose of the combined variable was to capture the degree of engagement in either genetic counseling or testing. Our prior qualitative work showed that many women fail to differentiate genetic counseling and testing (Sheppard et al. 2014) . We aimed to create a score that captured awareness and participation in any GCT services and to be consistent with prior scoring of this variable (Sheppard et al. 2013 ).
Predictors
Psychosocial Factors Psychosocial factors included breast cancer genetics knowledge, self-efficacy, perceived cancer-related stress, perceived risk of developing breast/ovarian cancer again, worry about developing breast/ovarian cancer again, and medical mistrust. Breast cancer genetics knowledge was the main predictor and was assessed with 13-items from Erblich and colleagues' scale (Erblich et al. 2005) where participants had to evaluate whether statements about breast cancer genetics were true or false. The numbers of correct responses were added to create a score ranging from 0-13. Higher scores mean higher breast cancer genetics knowledge. Self-Efficacy in obtaining GCT was measured with three-item 5-point Likert-type scale developed for this research (alpha = .75; Sheppard et al. 2013) . Participants were asked to rate their degree of agreement (ranging from strongly agree to strongly disagree) with three items about participants' self-confidence in locating GCT services, knowing how to pay for those services, and knowing what to do with the information obtained. Higher values indicate higher GCT self-efficacy. Risk perception of developing breast/ovarian cancer again was measured with one 5-response Likert item that assessed participants' perceptions about their likelihood of developing breast or ovarian cancer again. The five response choices ranged from Bnot at all likely^to Bdefinitely.^Worry of developing breast/ovarian cancer again was assessed with one 4-response item that queried how often participants had been worried about their chances of getting breast or ovarian cancer again. Response options included Bnot at all or rarely,B sometimes,^Boften,^and Ba lot.^Medical Mistrust was assessed using the 7-item Medical Mistrust Index (MMI; LaVeist et al. 2009 ), that examines participants' levels of mistrust in the American medical system on a 5-point Likert-type response scale ranging from Bstrongly agree^to Bstrongly disagree^(alpha = .76). An overall score was created by summing items together; higher values reflect greater medical mistrust (range 7-35). We measured perceived cancerrelated stress with a 5-item Likert-type scale developed by Halbert and colleagues (Halbert et al. 2004 ) that assessed participants' levels of perceived cancer-related stress regarding: coping with the risk of cancer recurrence, making riskreduction decisions, screening, communicating test results to relatives, and dealing with the impact of results on family members (alpha =.80). The four response choices ranged from Bnot at all stressful^to Bvery stressful.^Higher scores indicated higher perceived cancer-related stress.
Sociodemographic factors included age, educational level (categorized as high school, any college, and post-college), and marital status (categorized as married or living as married or divorced, separated, or other). Clinical cancer staging was recorded as breast/ovarian cancer stages 0-IV.
Data Analysis
Breast cancer genetics knowledge was the primary predictor variable of interest in predicting GCT engagement. We also examined the cancer stage, socio-demographic, and psychosocial predictors of breast cancer genetics knowledge. Statistical analysis using multiple regression and ordinal regression were used for multivariable analysis. The first model utilized Bknowledge^as the response variable in a multiple regression and the second model used BGCT engagement^as the response variable in an ordinal regression. Initial variables in both models were selected based on significant bivariate correlations (using Pearson's r for the Knowledge model and Spearman's rho for the GCT engagement model) at the .1 level. The final model for both response variables was based on backwards elimination method with a p-value of .05 as the criteria to remain in the model. All analyses were performed in SPSS version 23.0 (IBM 2015).
Results
Sociodemographic, Clinical, and Psychosocial Characteristics
The average age of participants (n = 50) was 51 years old (M = 51.15, SD = 10.16). Forty-two percent reported being married or living as married. Most women (84 %) had at least some college education or more and were covered by health insurance (96 %). Most participants (98 %) had been diagnosed with breast cancer; of which 88 % were diagnosed between stages 0-III. The only ovarian cancer survivor was diagnosed with stage III (2 %). Almost half of the sample (48 %) had been referred or had used GCT services whereas 14 % were unaware of GCT and 38 % had not been referred despite of being aware about GCT. Knowledge about breast cancer genetics ranged from 0 to 13 and was overall moderate (M = 7.78, SD = 1.61). Perceived risk of developing breast/ ovarian cancer was low, with 74 % reporting that they were not at all likely or a little bit likely to develop breast/ovarian cancer again. Similarly, more than half of the survivors (56 %) reported being not at all or rarely worried about developing breast/ovarian cancer again. Perceived self-efficacy to engage in GCT was relatively high as well as perceived cancer-related stress, and medical mistrust (see Table 1 ).
Factors Associated with Breast Cancer Genetics Knowledge
In the bivariate analysis age and stage were inversely correlated with breast cancer genetics knowledge. That is, survivors who were younger and those who were diagnosed with a lower cancer stage had higher knowledge levels (see Table 2 ). In the multivariable analysis both age and stage remained significant (Table 3) .
Factors Associated with GCT Engagement
Breast cancer genetics knowledge and self-efficacy were significantly positively correlated with GCT engagement, while stage presented a significant negative correlation with GCT engagement (all p < .05). Participants who scored higher on breast cancer genetics knowledge, those with higher self-efficacy to use GCT services, and those with lower stages had higher levels of GCT engagement (see Table 4 ). Only breast cancer genetics knowledge and self-efficacy remained significant in the multivariable analysis (see Table 5 ).
A sensitivity analysis with the software G*power (Faul et al. 2009 ) indicated that with a power of .8, alpha level of .05, sample size of 50, and with 5 predictor variables we would be able to detect a small to medium effect size of .21.
Discussion
To our knowledge, this is the first study to report the association between knowledge and GCT engagement in a sample of Black cancer survivors at increased risk of HBOC. Our study results demonstrated that at-risk Black breast cancer survivors had suboptimal engagement in GCT and GCT referrals. Additionally, HBOC knowledge was intermediate. Higher knowledge and higher ratings of self-efficacy were associated with higher GCT engagement after controlling for stage and several psychosocial factors. Taken together these findings have relevance for future interventions to improve GCT uptake such as the need to improve GCT referrals and potential intervention targets such as knowledge and self-efficacy.
Less than half of our sample (48 %) was referred to GCT services. The low referral rate is in concert with a study of atrisk affected and unaffected Black women that found that 68 % reported receiving a physician recommendation for genetic counseling (Thompson et al. 2012) . Similarly, in a sample of 48 young (≤ 50 years of age) Black breast cancer survivors, only 38 % of those who met NCCN guidelines for testing were referred for genetic counseling (Pal et al. 2013) . Since receipt of a provider referral is a key predictor of GCT uptake (Schwartz et al. 2005) , the fact that more than half of the sample had not been referred is important. NCCN guidelines recommend GCT referrals for women who are at risk of HBOC based on family history and personal cancer history. Some of the risk criteria for survivors (e.g. early-age-onset at ≤50, or triple negative breast cancer at ≤60; National Comprehensive Cancer Network 2015) are especially pertinent for Black survivors as they tend to be diagnosed at a younger age and they tend to have a higher rate of triple negative breast cancer than Whites (DeSantis et al. 2014) . Since this study sample was only composed of Black atrisk survivors, low referral rates highlights opportunities that were missed to inform and refer at-risk survivors for GCT. One study from a population-based registry (Jagsi et al. 2015) showed that a substantial percentage of survivors reported unmet needs for genetic testing discussion. Compared to Whites, Black women were almost twice as likely of reporting a lack of discussion about genetic testing with providers despite having a strong desire for testing.
The lower referrals may reflect lower knowledge among some providers; some data suggests that ethnic minorities tend to have less access to knowledgeable providers, tend to receive less-than-standard treatment, and lower referrals to screening than Whites (Forman and Hall 2009; Wheeler et al. 2013) .
As hypothesized, knowledge was positively associated with GCT engagement, supporting prior research (Donovan and Tucker 2000; Halbert et al. 1997; Kinney et al. 2006; Thompson et al. 2002) . The level of knowledge was intermediate, which is in concert with previous studies with samples of Black women mostly not at-risk (Donovan and Tucker 2000; Thompson et al. 2002) or mostly at risk but unaffected (Halbert et al. 1997; Kinney et al. 2006) . Since this study only included at-risk survivors, a higher knowledge level would have been expected (Sheppard et al. 2014) . The finding that age was inversely associated with HBOC knowledge may be because younger age at diagnosis is one of the predictors of being a BRCA1/2 mutation carrier (Nanda et al. 2005) . Thus, younger women may be more exposed to HBOC information. Studies with larger samples are needed to confirm the finding that lower stage was associated with higher HBOC knowledge and to explore the underlying reasons.
Given the important role of knowledge in GCT engagement and the moderate knowledge levels, enhancing survivors' knowledge across ages and stages via patient education will be important. Understanding genetic risk information is complex and it is associated with health literacy and numeracy skills (Kaphingst et al. 2015) . Research on how literacy and numeracy impact genomic information is lacking, especially in ethnic minorities (Lea et al. 2011 ). Only few interventions to enhance GCT knowledge and GCT uptake have included or targeted at-risk Black women (Baty et al. 2003; Charles et al. 2006; Halbert et al. 1997 ). Thus, developing and testing interventions to explore successful education strategies at increasing knowledge levels in this population is warranted.
In this study self-efficacy was operationalized as a woman's self-confidence in her ability to locate, pay for GCT services, and to know what to do with the information obtained. Self-efficacy was a robust predictor of GCT engagement which suggests the need of developing strategies to enhance self-efficacy among this population. These strategies may include patient navigation to address logistic barriers (e.g. transportation, coverage) and to provide information about treatment and surveillance options that women can take based on their test decisions. Educating patient navigators on cancer genetic services and resources where they can refer atrisk women will be a key step to enhance GCT engagement in underserved populations.
Our results differ from those that found psychosocial factors of medical mistrust and perceived risk of cancer to be correlated with GCT engagement (Armstrong et al. 2005; Halbert et al. 2010; Lipkus et al. 1999; Sheppard et al. 2013) , which may be due to the fact that our sample was comprised of only Black at-risk survivors. It is noteworthy that most survivors in this study sample had low reported rates of risk perception for developing a new cancer, which was also found in Brewster and colleagues' study (Brewster et al. 2007 ) with Black at-risk survivors. Since BRCA1/2 mutation carriers have approximately 50 % risk of developing contralateral breast cancer (Graeser et al. 2009; Metcalfe et al. 2004) , risk education in this population would be important to inform treatment decisions and surveillance. 
Practice Implications
This study has implications for providers who assess and discuss breast cancer risk, screening, and prevention with patients. Studies are ongoing to determine how treatments affect patients with genetic mutations differently (Smith and Isaacs 2011) and may provide oncologists with ways to personalize treatment in the future. It will be important that providers are educated about genetic and racial trends/probabilities and that they are equipped with the skills to discuss genetic risk information and to provide the appropriate referrals for women atrisk of HBOC and family members of those affected. Genetic counselors in particular can play a key role in reaching out to primary care providers in community clinics to provide information about HBOC, guidelines to identify at-risk patients, and referral strategies for patients who may be unaware about their HBOC risk.
Research Recommendations
Black women at-risk of HBOC are underrepresented in research studies (Sherman et al. 2013) . Few studies have only focused on Black at-risk populations (Brewster et al. 2007; Halbert et al. 2012; Pal et al. 2013) . Since Black women underuse GCT (Levy et al. 2011) , future studies with larger samples of at-risk Black women are needed to further our understanding of the factors associated with GCT use in this population to inform interventions aimed at decreasing GCT disparities.
Study Limitations
This study had some caveats. The lack of manipulated independent variables and cross-sectional design of the study prevents us from making causality inferences. Additionally, the small sample size and the fact that participants were mostly insured survivors and recruited only in a mid-Atlantic area, limits our ability to generalize findings to the uninsured and to Black at-risk survivors from other areas and to at-risk Black women not affected by breast cancer. The fact that this was a convenience sample recruited mostly through community outreach prevented us from obtaining a participation response rate, which limited our ability to judge the representativeness of the sample. This form of recruitment also prevented use of Despite the limitations, this study had several strengths including the unique sample of Black at-risk survivors and the measurement of several socio-demographic and psychosocial factors. Findings from this study suggest windows of opportunity to develop interventions with at-risk Black survivors that can ultimately reduce disparities. These windows of opportunity include the development of interventions to increase breast cancer genomics knowledge and self-efficacy at obtaining the services as well as interventions targeted to improving providers' referrals skills.
